Skip to main content
Clinical Trials/CTRI/2023/04/051411
CTRI/2023/04/051411Not yet recruitingUnknown

Efficacy of systemic administration of Omega 3 fatty acids when used as adjuvants to scaling and root planing on serum Nuclear Factor Kappa B levels in patients with Rheumatoid Arthritis and Periodontitis.

Panineeya Institute of Dental Sciences and Research centre0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients with Rheumatoid arthritis.
  • Patients with Chronic periodontitis.
  • For Periodontitis: 20 teeth should be present with probing pocket depths >= 5mm in one or more sites.
  • Rheumatoid arthritis patients with Anti-CCP levels Positive for antibodies â?? ( >20u/ml)

Exclusion Criteria

  • Pregnant and lactating women, Smokers, Patients with any auto immune or systemic disorder other than Rheumatoid arthritis.
  • Use of Medicines (other than RA medicines) or antibiotics 3 months before the commencement of the study.
  • History of periodontal treatment within 6 months.

Investigators

Sponsor
Panineeya Institute of Dental Sciences and Research centre

Similar Trials